XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS’ (DEFICIT) EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Preferred Stock
Class S Stock
Common Stock
Additional Paid-in Capital
Loans to Related Parties
Accumulated Deficit
Beginning balance (in shares) at Dec. 27, 2020   62,562,051 0 16,731,625      
Beginning balance at Dec. 27, 2020 $ (307,362) $ 505,638 $ 0 $ 17 $ 19,662 $ (4,000) $ (323,041)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss $ (86,994)           (86,994)
Exercise of stock options (in shares) 5,143,937     5,147,748      
Exercise of stock options $ 25,315     $ 5 25,310    
Exercise of common stock warrants (in shares)       14,333      
Exercise of common stock warrants 32       32    
Issuance of stock (in shares)   6,669,146 1,843,493        
Issuance of stock 30,704 $ 108,858 $ 2   30,702    
Stock-based compensation expense 5,929       5,929    
Repayment of related party loan 5,159       1,159 4,000  
Ending balance (in shares) at Sep. 26, 2021   69,231,197 1,843,493 21,893,706      
Ending balance at Sep. 26, 2021 (327,217) $ 614,496 $ 2 $ 22 82,794 0 (410,035)
Beginning balance (in shares) at Jun. 27, 2021   69,231,197 0 17,635,784      
Beginning balance at Jun. 27, 2021 (357,428) $ 614,496 $ 0 $ 18 26,523 (4,000) (379,969)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (30,066)           (30,066)
Exercise of stock options (in shares)       4,243,589      
Exercise of stock options 21,550     $ 4 21,546    
Exercise of common stock warrants (in shares)       14,333      
Exercise of common stock warrants 32       32    
Issuance of stock (in shares)     1,843,493        
Issuance of stock 30,704   $ 2   30,702    
Stock-based compensation expense 2,832       2,832    
Repayment of related party loan 5,159       1,159 4,000  
Ending balance (in shares) at Sep. 26, 2021   69,231,197 1,843,493 21,893,706      
Ending balance at Sep. 26, 2021 (327,217) $ 614,496 $ 2 $ 22 82,794 0 (410,035)
Beginning balance (in shares) at Dec. 26, 2021   0 0 109,345,697      
Beginning balance at Dec. 26, 2021 653,117 $ 0 $ 0 $ 109 1,129,224 0 (476,216)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss $ (136,630)           (136,630)
Exercise of stock options (in shares) 819,454     819,454      
Exercise of stock options $ 3,978     $ 2 3,976    
Issuance of common stock related to restricted shares (in shares)       587,629      
Stock-based compensation expense 62,973       62,973    
Ending balance (in shares) at Sep. 25, 2022   0 0 110,752,780      
Ending balance at Sep. 25, 2022 583,438 $ 0 $ 0 $ 111 1,196,173 0 (612,846)
Beginning balance (in shares) at Jun. 26, 2022   0 0 109,963,357      
Beginning balance at Jun. 26, 2022 612,183 $ 0 $ 0 $ 110 1,177,522 0 (565,449)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (47,397)           (47,397)
Exercise of stock options (in shares)       258,844      
Exercise of stock options 1,051     $ 1 1,050    
Issuance of common stock related to restricted shares (in shares)       530,579      
Stock-based compensation expense 17,601       17,601    
Ending balance (in shares) at Sep. 25, 2022   0 0 110,752,780      
Ending balance at Sep. 25, 2022 $ 583,438 $ 0 $ 0 $ 111 $ 1,196,173 $ 0 $ (612,846)